Vancouver, British Columbia--(Newsfile Corp. - June 10, 2026) - Planet Ventures Inc. (CSE: PXI) (OTC Pink: PNXPF) (FSE: P6U) ("Planet" or the "Company") is pleased to highlight a significant milestone achieved by its portfolio company, Antaris, follo

Vancouver, British Columbia--(Newsfile Corp. - June 10, 2026) - Makenita Resources Inc. (CSE: KENY) (WKN: A40X6P) (OTCID: KENYF) ("Makenita" or the "Company") wishes to announce that it has elected to rely on Coordinated Blanket Order 51-933 Exemptio

Live demonstrations highlight real-time power control, efficiency and system performance across AI data center, EV and high-power applicationsNUREMBERG, Germany, June 10, 2026 (GLOBE NEWSWIRE) -- Skyworks Solutions, Inc. (Nasdaq: SWKS), a leading dev

Vancouver, British Columbia--(Newsfile Corp. - June 10, 2026) - Ynvisible Interactive Inc. (TSXV: YNV) (FSE: 1XNA) (OTCQB: YNVYF) (the "Company" or "Ynvisible"), a leader in printed e-paper display solutions, today announced an operational update hig

Huw van Steenis to Join as European Economic & Policy Strategist Sarah Jenkins to Join as Head of Government Affairs, Europe LONDON and NEW YORK, June 10, 2026 (GLOBE NEWSWIRE) -- Apollo (NYSE: APO) today announced that Huw van Steenis will join the

Applied Materials Tampines Campus in Singapore Applied Materials Tampines Campus in Singapore New state-of-the-art facility strengthens Applied’s global manufacturing and R&D capabilities to drive resilience and scalabilityTampines Campus sets a new

AUSTIN, Texas and DURHAM, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of potentially first-in-class monoclonal and bispeci

BOSTON, June 09, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (“Tango”) (Nasdaq: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, announced today the pricing

CAMBRIDGE, Mass., June 09, 2026 (GLOBE NEWSWIRE) -- Parabilis Medicines, Inc. (Nasdaq: PBLS) (“Parabilis”), a clinical-stage biopharmaceutical company built to develop transformative medicines addressing some of the most consequential, yet historical

Vancouver, British Columbia--(Newsfile Corp. - June 9, 2026) - Entheon Biomedical Corp. (CSE: ENBI.X) (OTCID: ENTBF) (FSE: 1XU) ("Entheon" or the "Company") wishes to correct the effective date of the appointment of Adam Emes as a director of the Com